PTV Sciences is a life science venture capital and private equity firm focused on enabling healthcare entrepreneurs and global innovation. We are a highly collaborative investment team of 22 professionals, deeply experienced as investors and operators of life science companies. PTV Sciences focuses on enabling industry leading companies and investing in extraordinary people in the healthcare and life sciences sector, including medical devices, biotechnology, pharmaceuticals, and diagnostics.

The Firm was founded in 2003 to invest in growth opportunities in the healthcare and life sciences sector. We invest in companies across the United States leveraging world-renowned resources in Texas to create disruptive technology, compelling investment opportunities, and life-saving change. Much like the untapped reserves which created the modern day oil and gas industry, the Texas region and the Southern United States has a wealth of untapped resources in its academic institutions and research centers. The Firm has the benefit of the direct experience and support of the research institutions, academic centers, foundations, family offices, and entrepreneurs: the "pillars of Texas" who over the last century have been investing in and building sustainable, successful companies in healthcare, energy, finance, telecommunications, information technology, agriculture, and real estate.
 

Mark McClellan, M.P.A., M.D., Ph.D., Former Commissioner of the Food and Drug Administration, will Serve As Honorary Chair and Keynote Speaker at the PTV Sciences Annual Meeting

PTV Sciences Announces Expanded Role for Stephen Slade, M.D. and an Increased Strategic Focus on Ophthalmology

PTV Sciences Announces New Venture Partner Woodrow A. Myers, Jr., M.D.